Tower Capital Asia is repositioning itself as a large, globally connected PE firm as it transitions from deal-by-deal investing to a fund structure. Deep roots in Singapore remain the nucleus of the strategy
Singapore’s Tower Capital Asia had seen significant success working on a deal-by-deal basis, so LPs were not expecting meaningful change in strategy or structure when the firm launched its debut blind...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.